Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C.

Schmitz, Anna H; Wood, Kelly E; Burghardt, Elliot L; Koestner, Bryan P; Wendt, Linder H; Badheka, Aditya V; Sharathkumar, Anjali A

Schmitz, Anna H; Wood, Kelly E; Burghardt, Elliot L; Koestner, Bryan P; Wendt, Linder H; Badheka, Aditya V; Sharathkumar, Anjali A.

Afiliación

Schmitz AH; Stead Family Department of Pediatrics University of Iowa Iowa City Iowa USA.
Wood KE; Carver College of Medicine University of Iowa Iowa City Iowa USA.
Burghardt EL; Stead Family Department of Pediatrics University of Iowa Iowa City Iowa USA.
Koestner BP; Carver College of Medicine University of Iowa Iowa City Iowa USA.
Wendt LH; Carver College of Medicine University of Iowa Iowa City Iowa USA.
Badheka AV; Department of Biostatistics, College of Public Health University of Iowa Iowa City Iowa USA.
Sharathkumar AA; Stead Family Department of Pediatrics University of Iowa Iowa City Iowa USA.

Res Pract Thromb Haemost ; 6(5): e12780, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35949885

Palabras clave

COVID19; MISC; anticoagulants; child; heparin; low molecular weight; thrombosis; venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google